Factors Moving Markets: Complementary Research on Fairchild, CNH Industrial, Synta Pharmaceuticals, Jumei International, Pacira Pharmaceuticals

NEW YORK, April 21, 2015 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.  

Moments ago, Analysts Review released new research updates concerning several important developing situations including Fairchild (NASDAQ: FCS), CNH Industrial (NYSE: CNHI), Synta Pharmaceuticals (NASDAQ: SNTA), Jumei International (NYSE: JMEI), and Pacira Pharmaceuticals (NASDAQ: PCRX). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.

To access our full PDF reports on a complementary basis, please visit the links below.

--

Today's update concerns the following companies:

============

Full PDF Download Links (you may have to copy and paste the following links into your browser):

FCS Research Report: ( http://get.analystsreview.com/pdf/?c=Fairchild%20Semiconductor&d=21-Apr-2015&s=FCS ),

CHN Research Report: ( http://get.analystsreview.com/pdf/?c=CNH%20Industrial&d=21-Apr-2015&s=CHN ),

SNTA Research Report: ( http://get.analystsreview.com/pdf/?c=Synta%20Pharmaceuticals&d=21-Apr-2015&s=SNTA ),

JMEI Research Report: ( http://get.analystsreview.com/pdf/?c=Jumei%20International&d=21-Apr-2015&s=JMEI ),

PCRX Research Report: ( http://get.analystsreview.com/pdf/?c=Pacira%20Pharmaceuticals&d=21-Apr-2015&s=PCRX ).

============

--

Analyst Update: Financial Results,AGM Updates,Public Offering, Financial Results, Legal Updates

Reviewed by: Rohit Tuli, CFA®  

U.S. stocks rallied on Monday, triggered by some good first-quarter earnings reports. The NASDAQ gained 1.27% or 62.79 points, to finish at 4,994.60; the Dow Jones Industrial Average advanced 1.17%, or 208.63 points to 18,034.93, and the S&P 500 ended the session at 2,100.40, up 0.92% or 19.22 points. The gains were broad based as all the sectors closed the session in positive. European stocks too edged higher on Monday, as aggressive easing policy in China offsets the impact of Greece turmoil. Major European markets ended the session higher, as Germany's DAX rose 1.74%; France's CAC advanced 0.86%, and Britain's FTSE 100 jumped 0.82%. Meanwhile, Asian markets mostly disappointed on Monday, amid rising concern over slowdown in the Chinese economy. The Shanghai Composite and Japan's Nikkei both closed lower.

Fairchild reported Q1 2015 total sales of $355.7 million, up 6% from the previous quarter and up 3% YoY. Net income stood at $1.1 million or $0.01 per diluted share, compared to net losses of $42.7 million or $0.36 per diluted share in the prior quarter and $9.3 million or $0.07 per diluted share in the first quarter of 2014.

CNH Industrial (CNH Industrial) informed that at its annual general meeting the Company's shareholders has approved its 2014 EU Annual Report and has declared a dividend of €0.20 per common share, equivalent to a total distribution of approximately €272 million.

Synta Pharmaceuticals (Synta) announced of closing its underwritten public offering of 25.3 million shares of common stock, including 3.3 million shares sold pursuant to the full exercise of the option to purchase additional shares previously granted to the underwriters, at a public offering price of $1.75 per share.

Jumei International (Jumei), China's leading online retailer of beauty products, reported its Q4 2014 and full year 2014 financial results. Net revenues increased by 18.5% YoY to $166.0 million in Q4 2014, while for the whole year it increased at a faster pace of 31.0% YOY to $632.9 million.

Pacira Pharmaceuticals share price plunged by 9.7% on April 16, 2015 following reports that the Company has received a subpoena from the U.S. Department of Justice, U.S. Attorney's Office for the District of New Jersey.

--

About Analysts Review  

At Analysts Review, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

Analysts Review was designed for investors. By providing the best information available, we have set ourselves apart as one of the premier online investor communities.

--

Editor Note: This is not company news. We are an independent source and our views do not reflect the companies mentioned.

Compliance Procedure: Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA®. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

Further Resources: For more information about this release including editorial notes, compliance procedures and legal disclosures, please visit: http://www.analystsreview.com/editors

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review